drugset / Trial / NCT00004398
Phase I Study of Heme Arginate With or Without Tin Mesoporphyrin in Patients With Acute Attacks of Porphyria
Phase 1
Completed
24 enrolled
National Center for Research Resources (NCRR)
University of Texas · collab
RandomizedOpen-labelTreatment
Summary
OBJECTIVES: I. Evaluate the efficacy of tin mesoporphyrin in patients with acute porphyria attacks who are also treated with a standard course of heme arginate. II. Evaluate the safety and tolerability of tin mesoporphyrin when administered to these patients.
Timeline
- Start
- 1998-01
- Primary completion
- —
- Completion
- 2000-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | stannsoporfin | Small molecule | — | Intravenous |
| Background | heme arginate | Small molecule | — | — |